Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Iprad is a prominent French pharmaceutical group dedicated to women's health and family wellbeing. Established in 1989, the company is widely recognized for its flagship brand Saforelle, which is a leader in the French market for intimate hygiene, alongside other specialized brands like Gestarelle and Mucogyne. In 2010, Iprad expanded its portfolio by acquiring Laboratoires Vegebom, a specialist in phytotherapy known for its multi-purpose plant-based balms for skin and muscle relief. The company was acquired by the international pharmaceutical group Biocodex in 2020, integrating its expertise in gynecology and consumer health into Biocodex's global operations. Iprad's product range spans medications, medical devices, and food supplements, with a strong emphasis on natural ingredients and clinical efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Iprad-Vegebom.